Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis
2 other identifiers
interventional
15
0 countries
N/A
Brief Summary
OBJECTIVES: I. Investigate the efficacy and safety of colchicine therapy in improving hepatic function and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 1990
CompletedFirst Submitted
Initial submission to the registry
October 18, 1999
CompletedFirst Posted
Study publicly available on registry
October 19, 1999
CompletedJune 24, 2005
October 1, 2003
October 18, 1999
June 23, 2005
Conditions
Keywords
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ronald J. Sokol
Children's Hospital Colorado
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Purpose
- TREATMENT
- Sponsor Type
- NIH
Study Record Dates
First Submitted
October 18, 1999
First Posted
October 19, 1999
Study Start
May 1, 1990
Last Updated
June 24, 2005
Record last verified: 2003-10